Discussion Topic: Stroke and Bleeding Risks of Endocardial Ablation for Ventricular Arrhythmias
William H. Sauer, MD, FHRS, CCDS of Brigham and Women’s Hospital, is joined by Uyanga Batnyam, MD of the University of Washington and Usha B. Tedrow, MD, MS, FHRS of Brigham and Women`s Hospital to discuss the risks of radiofrequency catheter ablation for ventricular arrhythmias include emboli and bleeding complications but data on antithrombotic regimens are limited and guidelines do not specify a systematic approach. This study sought to assess embolic and bleeding complications in relation to pre- and postperiprocedure antithrombotic regimens. Stroke is a rare complication of radiofrequency catheter ablation for ventricular arrhythmia using ASA 325 mg/d as a minimal postprocedure regimen with more potent regimens for selected patients.
Host: William H. Sauer, MD, FHRS, CCDS
Guests: Uyanga Batnyam, MD and Usha B. Tedrow, MD, MS, FHRS
Speaker and Article Information: Download
Visual Aid: Download
Topic
- The Lead
Resource Type
- Podcasts
Related Resources
The Lead
Podcasts
The Lead Episode 132: A Discussion of Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (English Language Episode)
January 15, 2026
The Lead
Podcasts
The Lead Episode 132: A Discussion of Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation (Japanese Language Episode)
January 15, 2026
The Lead
Podcasts
The Lead Episode 131: A Discussion of Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation: The DECAF Randomized Clinical Trial (Japanese Language Episode)
January 8, 2026